Aortic Stent Grafts Market Research Report, Analysis and Forecast – (2025 – 2030)

Aortic Stent Grafts Market Driven by Surge in Minimally Invasive Procedures 

The aortic stent grafts market is undergoing a significant transformation as healthcare systems worldwide prioritize minimally invasive interventions. The growing adoption of endovascular aneurysm repair (EVAR) and thoracic endovascular aortic repair (TEVAR) is accelerating the demand for aortic stent grafts, especially among the elderly who are most susceptible to aortic aneurysms. Currently, over 65 percent of abdominal aortic aneurysm cases are managed using EVAR techniques, marking a decisive clinical shift. 

Minimally invasive approaches offer several advantages, such as reduced hospital stays, faster recovery, and decreased procedural risks. This transition not only supports improved patient outcomes but also reduces the burden on healthcare infrastructure. As hospitals align their surgical protocols with advanced endovascular technologies, the aortic stent grafts market continues to gain momentum on a global scale. 

Aging Population and Rising Cardiovascular Risk Amplify Aortic Stent Grafts Market Growth 

The aging global population remains a dominant driver of the aortic stent grafts market. Individuals over the age of 65 are at significantly higher risk of developing aortic aneurysms due to arterial wall degeneration. In many developed nations, individuals above 60 years of age now represent more than 70 percent of all diagnosed cases of aortic aneurysm. 

For example, with the number of senior citizens projected to grow rapidly over the next decade, the volume of aneurysm-related interventions is set to rise in parallel. Cardiovascular conditions such as hypertension, obesity, and diabetes further compound the risk of aneurysm formation. As a result, the expanding geriatric demographic, coupled with increasing chronic disease prevalence, directly supports growth in the aortic stent grafts market. 

Innovations in Product Design Fueling Aortic Stent Grafts Market Expansion 

Technological advancements in the design and functionality of stent grafts are redefining the competitive landscape of the aortic stent grafts market. Recent product innovations include the development of branched and fenestrated grafts, modular systems, and low-profile delivery platforms. These devices are engineered to address complex anatomical challenges, making them suitable for a broader patient population. 

For instance, new stent grafts now offer greater conformability and enhanced sealing capabilities, reducing the risk of endoleaks and procedural failures. Modular designs are also gaining traction, particularly for patients with highly angulated or tortuous aortic anatomies. These advancements are not only improving patient safety but also expanding treatment access, accelerating the overall growth of the aortic stent grafts market. 

Widespread Acceptance of Endovascular Repair Boosts Aortic Stent Grafts Market 

The global healthcare industry is seeing an evident shift from open surgical repair to endovascular solutions. This shift is a major tailwind for the aortic stent grafts market. Endovascular techniques are increasingly preferred due to their lower complication rates, shorter hospital stays, and improved clinical outcomes, particularly for high-risk surgical candidates. 

Procedural volumes for TEVAR and EVAR are growing steadily, with more than 75 percent of thoracic aortic aneurysms now being managed endovascularly in several developed regions. This growth is supported by advancements in imaging technologies, increasing surgeon familiarity, and the development of supportive infrastructure in both public and private healthcare facilities. 

Infrastructure Development in Emerging Economies Strengthens Aortic Stent Grafts Market 

Emerging markets across Asia-Pacific, Latin America, and the Middle East are witnessing a rapid expansion in vascular surgery capabilities. As governments increase investments in tertiary care, the availability of advanced endovascular procedures is improving. This trend is unlocking new growth avenues for the aortic stent grafts market in these regions. 

For example, the rise in specialized cardiovascular centers, coupled with the growing number of trained vascular surgeons, is creating a fertile environment for the adoption of aortic stent grafts. With procedural awareness and diagnostic capabilities on the rise, these regions are expected to experience above-average market growth over the next decade. 

Aortic Stent Grafts Market Size Grows with Advancing Technologies 

The aortic stent grafts market size is witnessing notable growth, driven by a combination of rising procedure volumes and the premium pricing of advanced stent graft technologies. The global market value has expanded significantly in recent years and is expected to maintain a steady upward trajectory through the end of the decade. 

Newer generation devices, such as branched and fenestrated grafts, command higher price points due to their complexity and superior performance. The increasing average selling price, along with favorable reimbursement frameworks in several countries, is further contributing to the market size expansion. Hospitals and healthcare systems are recognizing the long-term cost benefits of these devices, especially in terms of reducing reintervention rates. 

Regulatory Progress and Clinical Outcomes Strengthen Aortic Stent Grafts Market Confidence 

The regulatory environment for aortic stent grafts has improved considerably over the past decade, allowing for faster product approvals and streamlined clinical adoption. Several high-performing devices have received market clearance in key regions, making them more accessible to healthcare providers. 

Clinical studies continue to demonstrate favorable long-term outcomes for patients treated with stent grafts. Five-year survival rates for patients undergoing EVAR now exceed 85 percent, compared to significantly lower outcomes with traditional surgical methods. These positive clinical results are driving surgeon confidence, supporting continued growth in the aortic stent grafts market. 

Strategic Collaborations and Value-Based Models Reshape Aortic Stent Grafts Market 

Healthcare institutions are increasingly adopting value-based procurement models, which is influencing the dynamics of the aortic stent grafts market. Hospitals and healthcare systems are entering into long-term strategic partnerships with device manufacturers to standardize care and optimize resource utilization. 

These collaborations often include outcome-based pricing models, bulk purchasing agreements, and shared performance metrics. Such models are helping providers reduce costs while maintaining access to high-quality devices. As a result, suppliers with proven product outcomes and strong support systems are becoming preferred partners, consolidating their position in the aortic stent grafts market. 

Training and Skill Development Key to Expanding Aortic Stent Grafts Market Access 

The growing complexity of aortic stent graft procedures highlights the need for ongoing training and professional development. Advanced procedures such as branched and fenestrated repairs require precise anatomical planning and a high degree of technical skill. Ensuring that vascular surgeons are equipped with the necessary training is essential for the successful expansion of the aortic stent grafts market. 

Leading device manufacturers and academic institutions are investing in simulation-based training centers and workshops to promote procedural excellence. These efforts are paying dividends in terms of improved patient outcomes, fewer complications, and increased confidence among healthcare providers to perform technically demanding interventions. 

 

North America Leads Global Aortic Stent Grafts Market with Strong Infrastructure and High Procedure Volumes 

The aortic stent grafts market in North America continues to dominate in terms of revenue share, driven by a combination of high awareness, established healthcare infrastructure, and advanced reimbursement systems. The United States alone accounts for over 40 percent of the global market, with procedure volumes rising steadily over the past five years. Datavagyanik highlights that the number of EVAR and TEVAR procedures performed annually in the U.S. has crossed 80,000, with growth projected at a compounded annual rate of 6 to 7 percent. 

This trend is supported by a large pool of trained vascular surgeons and widespread access to imaging and hybrid surgical suites. For example, over 90 percent of Level 1 trauma centers in the United States are now equipped to perform complex endovascular repairs, making aortic stent grafts the preferred intervention for aortic aneurysm management. The aging population and high prevalence of cardiovascular risk factors, such as hypertension and obesity, further elevate aortic stent grafts demand across the region. 

Europe’s Aortic Stent Grafts Market Fueled by Rising Preference for Advanced Endovascular Procedures 

Europe represents a highly structured aortic stent grafts market, supported by robust clinical guidelines and centralized procurement systems. Countries such as Germany, France, and the United Kingdom have seen a sharp uptick in endovascular aneurysm repair adoption. In Germany, more than 70 percent of abdominal aortic aneurysm cases are now treated using EVAR, reflecting the growing shift toward minimally invasive alternatives. 

The aortic stent grafts market in Europe is also benefiting from government-sponsored programs aimed at reducing surgical wait times and improving access to advanced devices. For instance, the inclusion of TEVAR under national health insurance coverage in several European countries has significantly improved patient access to next-generation thoracic grafts. Datavagyanik projects that Europe will maintain steady annual growth between 5 to 6 percent in the near term, underpinned by innovation, clinical efficacy, and structured healthcare delivery. 

Asia-Pacific Emerges as High-Growth Region in Aortic Stent Grafts Market 

Asia-Pacific is experiencing an accelerated evolution in the aortic stent grafts market, driven by rapid improvements in healthcare infrastructure and increasing awareness of endovascular interventions. Countries like China, India, South Korea, and Japan are investing heavily in vascular surgery capabilities, supported by government health initiatives and private hospital expansion. 

In China alone, the annual number of aortic procedures has risen by more than 12 percent year-on-year, with tier-1 and tier-2 cities emerging as key growth nodes. Similarly, India is witnessing double-digit growth in the adoption of EVAR procedures, especially in metropolitan areas where hybrid operating rooms are becoming more common. Aortic stent grafts demand in Asia-Pacific is further amplified by an increase in lifestyle-related diseases and the growing availability of low-cost device alternatives. Datavagyanik expects the region to outpace global averages, achieving growth above 10 percent annually through the end of the decade. 

Latin America Expands Slowly but Steadily in Aortic Stent Grafts Market 

Latin America’s aortic stent grafts market is in the early stages of development but shows promising potential, particularly in Brazil, Mexico, and Argentina. Limited access to specialized healthcare facilities and uneven distribution of vascular expertise have historically constrained procedural growth. However, recent years have seen increased investment in tertiary care centers and an influx of international medical device manufacturers entering the region. 

For example, Brazil has implemented new regulatory reforms aimed at expediting device approvals, allowing for greater penetration of advanced stent grafts. Aortic stent grafts demand is beginning to build momentum as more hospitals incorporate EVAR and TEVAR into their surgical portfolios. While the market is expected to grow at a more modest rate compared to Asia-Pacific or North America, its untapped potential positions it as an important region for long-term expansion. 

Middle East and Africa Show Early-Stage Growth in Aortic Stent Grafts Market 

The aortic stent grafts market in the Middle East and Africa is gradually gaining attention, supported by efforts to modernize healthcare systems and attract foreign medical expertise. Countries like Saudi Arabia, the United Arab Emirates, and South Africa are making progress in developing cardiovascular treatment hubs, which include capabilities for endovascular interventions. 

Although the overall procedure volumes remain low, the region is experiencing increasing aortic stent grafts demand as chronic disease rates escalate and governments push for improved care delivery. Strategic partnerships between public hospitals and global device manufacturers are helping bring advanced graft technologies to local populations. Datavagyanik indicates that the market will expand gradually, with most of the near-term growth focused in urban centers with specialized surgical infrastructure. 

Aortic Stent Grafts Market Segmentation by Product Type Reflects Diverse Clinical Needs 

The aortic stent grafts market is segmented based on product type into abdominal aortic stent grafts and thoracic aortic stent grafts. Abdominal aortic stent grafts currently account for the majority market share, largely due to the higher incidence of abdominal aortic aneurysms among the aging population. However, thoracic aortic stent grafts are experiencing faster growth rates, supported by technological innovations and broader clinical applications. 

For instance, thoracic stent grafts are increasingly being used in emergency trauma cases and dissections, areas where they previously had limited utility. Branched and fenestrated thoracic devices, in particular, are expanding therapeutic options for complex anatomies. Datavagyanik forecasts that thoracic stent grafts will account for more than 40 percent of the total aortic stent grafts market by the end of the decade. 

Hospital and Specialty Clinic Segments Drive Aortic Stent Grafts Market by End Use 

By end use, the aortic stent grafts market is predominantly led by hospitals, which perform the bulk of EVAR and TEVAR procedures. These institutions possess the necessary imaging, surgical, and post-operative care infrastructure required for successful intervention. Teaching hospitals and academic medical centers, in particular, account for a large percentage of high-complexity cases involving customized grafts. 

Specialty clinics, including vascular surgery centers and heart institutes, are gaining share as technology becomes more portable and accessible. These centers are also benefiting from faster decision-making, lean operational structures, and growing insurance acceptance for elective procedures. As the market matures, the role of outpatient vascular care facilities is expected to increase, especially in urban settings with high patient density. 

Price Trends in Aortic Stent Grafts Market Influenced by Innovation and Procurement Models 

Pricing dynamics in the aortic stent grafts market are shaped by several interrelated factors including product complexity, regulatory compliance, and competitive landscape. Branched and fenestrated grafts, for example, are priced at a 20 to 30 percent premium over standard grafts due to their design sophistication and limited manufacturing scale. These advanced devices often require patient-specific customization, further driving up unit costs. 

At the same time, high-volume hospitals and healthcare systems are leveraging their purchasing power through group procurement contracts and performance-based agreements. These arrangements are influencing the average selling price across developed markets, where bundled payments and outcome-linked pricing are increasingly common. Datavagyanik notes that while average prices remain high, market forces are driving gradual price stabilization, especially in regions with strong competition and tender-based procurement. 

Aortic Stent Grafts Demand Shaped by Rising Complexity of Treated Cases 

Aortic stent grafts demand is also evolving based on the complexity of aortic cases being treated. As procedural expertise increases, more patients with tortuous anatomy, severe comorbidities, or previous surgical repairs are now eligible for endovascular interventions. This shift is creating demand for specialized graft configurations, including branched and fenestrated options that command higher price points. 

For example, tertiary care centers report that nearly 30 percent of aortic aneurysm cases now involve anatomical features that would have previously ruled out endovascular repair. With device innovation keeping pace with clinical needs, these cases are increasingly being treated successfully, further increasing aortic stent grafts demand across both high-income and developing countries. 

Future Outlook on Aortic Stent Grafts Market Supported by Economic and Clinical Validation 

Looking ahead, the global aortic stent grafts market is expected to remain on a growth trajectory driven by economic factors, technological advancement, and expanding procedural volumes. Clinical validation and improved long-term outcomes continue to reinforce the preference for endovascular solutions across patient and provider groups. 

Healthcare systems are increasingly recognizing the value proposition of stent grafts, which combine cost-efficiency with strong clinical performance. As procedural volumes increase and manufacturing scales up, price moderation is expected, further enhancing accessibility and adoption. With rising aortic stent grafts demand and favorable geographic expansion, the market is set to deepen its footprint across all major healthcare regions. 

 

Leading Players in the Aortic Stent Grafts Market Drive Innovation and Competitive Differentiation 

The aortic stent grafts market is dominated by a select group of global players with deep technological capabilities, extensive clinical experience, and wide geographical reach. These companies are consistently shaping the market landscape through product innovation, regulatory approvals, and expansion into emerging economies. Competition is intensifying as companies push for higher market share by targeting both standard and complex aortic repair cases. 

Currently, the top five players account for a significant portion of the global aortic stent grafts market, collectively holding over 75 percent of total market share. These leaders include Medtronic, Cook Medical, Gore Medical, Terumo Aortic, and Endologix. Other players such as Cardinal Health, Jotec (CryoLife), Bentley InnoMed, and MicroPort are steadily expanding their regional presence and specialty product portfolios. 

Medtronic Leads Aortic Stent Grafts Market with Broad Portfolio and Global Reach 

Medtronic remains the largest stakeholder in the aortic stent grafts market, commanding an estimated 30 to 35 percent of global market share. The company’s success is anchored in its broad product line, including the Endurant II and Endurant IIs stent graft systems for abdominal aneurysms, and the Valiant Navion system for thoracic aneurysm repairs. 

Medtronic has built a reputation for clinical performance, reliability, and post-implant surveillance programs. Its devices are approved and widely used across North America, Europe, and Asia-Pacific. The company continues to invest in next-generation low-profile systems and is actively engaged in trials to support expanded indications for complex anatomies. 

Gore Medical Commands Strong Position in Thoracic Aortic Stent Grafts Market
L. Gore & Associates holds a substantial share in the thoracic segment of the aortic stent grafts market. Its flagship products include the GORE TAG Conformable Thoracic Stent Graft and the GORE EXCLUDER AAA Endoprosthesis for abdominal cases. The company is known for its strong focus on durability and conformability in challenging anatomical scenarios.

Gore’s systems are designed for precision deployment, and its portfolio is frequently selected for trauma-related thoracic injuries and descending thoracic aneurysms. With a growing number of centers adopting GORE TAG systems for TEVAR procedures, the company continues to strengthen its position in the mid to high-end segment of the market. 

Cook Medical Specializes in Customizable Aortic Stent Graft Solutions 

Cook Medical has secured a solid foothold in the aortic stent grafts market through its Zenith product family. The Zenith Flex, Zenith Alpha, and Zenith Fenestrated stent grafts are widely recognized for their use in both standard and complex aneurysm repairs. The company focuses on patient-specific customization, which has made it a preferred partner in high-risk and anatomically difficult cases. 

Cook Medical’s approach to graft planning and deployment has enabled it to lead in the fenestrated and branched graft space. It remains one of the few manufacturers with a complete suite of endovascular repair options from iliac to thoracic aorta, allowing it to serve a diverse clinical base. 

Terumo Aortic Focuses on Complex Aortic Repair and Hybrid Solutions 

Terumo Aortic, formerly Bolton Medical, has carved out a niche in complex aortic repair through its Relay and TREO stent graft systems. These products are frequently used in cases involving thoracoabdominal aneurysms, arch dissections, and high-risk patient populations. The company has been successful in aligning its offerings with evolving surgical techniques and hybrid procedures. 

With manufacturing capabilities in the US and Europe, Terumo Aortic is expanding its global footprint, especially in the Asia-Pacific region. The company is known for its agility in designing physician-modified grafts and its support for customized procedural planning, which gives it a strong clinical edge in non-standard applications. 

Endologix Emphasizes Disruptive Innovation in the Aortic Stent Grafts Market 

Endologix has emerged as an innovation-centric player in the aortic stent grafts market with products like AFX2 and the Nellix EndoVascular Aneurysm Sealing System. Although the Nellix system was temporarily withdrawn from some markets, Endologix continues to push boundaries in endovascular sealing technologies and inline fixation models. 

The company has positioned itself as a pioneer in addressing limitations of traditional EVAR systems, particularly in patients with short neck anatomies. With renewed clinical studies and FDA engagements, Endologix is attempting to re-enter the mainstream market with improved versions of its previous designs and focus on unmet surgical needs. 

Regional and Specialized Players Contribute to Aortic Stent Grafts Market Diversity 

In addition to global leaders, several regional players are making notable contributions to the aortic stent grafts market. Companies like MicroPort (China), Bentley InnoMed (Germany), and Jotec (now part of Artivion) are gaining recognition for their focus on physician-led design, affordability, and regional adaptability. 

These firms are particularly successful in cost-sensitive markets where high procedural volumes and government-funded healthcare systems require cost-efficient but clinically effective solutions. Their presence adds competition, especially in mid-tier and price-competitive segments of the market. 

Recent Developments and Industry News in the Aortic Stent Grafts Market 

The aortic stent grafts market has seen several strategic developments in the past two years, reflecting both technological progress and strategic alignment across key players. 

• In Q1 2023, Medtronic announced the expansion of clinical enrollment for its investigational next-generation abdominal system designed for use in short-neck aneurysms, signaling a continued push into high-risk anatomical categories. 

• In May 2023, Cook Medical introduced an enhanced version of its Zenith Alpha thoracic graft with improved flexibility and a lower delivery profile, aimed at expanding use in tortuous anatomies. 

• Gore Medical announced in late 2023 a broader rollout of its new GORE TAG Thoracic Branch Endoprosthesis in select European markets, marking an important milestone in addressing arch and branch vessel repairs. 

• Endologix confirmed in early 2024 its reentry into select clinical markets with a redesigned version of its Nellix system, along with new clinical partnerships in the United States and Europe. 

• Terumo Aortic shared plans in March 2024 to expand its Glasgow facility, focusing on scaling the production of customized fenestrated grafts, reflecting growing global demand for personalized aortic repair. 

These updates reflect a clear industry focus on innovation, precision treatment, and expanded access. As more companies invest in complex repair capabilities and global expansion, the competitive intensity in the aortic stent grafts market is expected to increase, driving the next phase of growth. 

 

Key Insights that the Aortic Stent Grafts Market analysis report presents are:

• Aortic Stent Grafts Market revenue and demand by countries
• Break-down of the Aortic Stent Grafts Market in terms of application areas, target customers, and other potential market segments
• Areas that are relatively more potential and are faster growing
• Aortic Stent Grafts Market competitive scenario, market share analysis
• Aortic Stent Grafts Market business opportunity analysis

Global and Country-Wise Aortic Stent Grafts Market Statistics

• Global and Country-Wise Aortic Stent Grafts Market Size ($Million) and Forecast – (2021-2028)
• Global and Country-Wise Aortic Stent Grafts Market Trend Analysis
• Global and Country-Wise Aortic Stent Grafts Market Business Opportunity Assessment